# An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants

> **NCT03712540** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 39 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986278
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT03712540
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-06
- **Primary completion:** 2018-11-08
- **Final completion:** 2018-11-08
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2019-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03712540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03712540, "An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03712540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*